<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04908878</url>
  </required_header>
  <id_info>
    <org_study_id>33972/7/20</org_study_id>
    <nct_id>NCT04908878</nct_id>
  </id_info>
  <brief_title>Combined PECS II and Transeversus Thoracic Plane Blocks Vs Serratus Anterior Plane Block in Modified Radical Mastectomy</brief_title>
  <official_title>Analgesic Efficacy of Combined Ultrasound-Guided PECS II and Transeversus Thoracic Plane Blocks Versus Ultrasound-Guided Serratus Anterior Plane Block in Modified Radical Mastectomy: A Prospective Randomized Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tanta University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tanta University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the analgesic efficacy of combined ultrasound&#xD;
      (US)-guided pectoral nerve (PECS) block II and transversus thoracic plane (TTP) block versus&#xD;
      US-guided serratus anterior plane (SAP) block in female patients undergoing modified radical&#xD;
      mastectomy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2021</start_date>
  <completion_date type="Anticipated">November 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 29, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The total amount rescue analgesic consumption (morphine) in the first 24 hours postoperatively.</measure>
    <time_frame>First 24 hours postoperatively.</time_frame>
    <description>Rescue analgesia in the form of morphine (3mg IV) will be given if the VAS is ≥ 40, repeated with lock out interval of 5 min guided with the occurrence of complications till the VAS is decreased to less than 40.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>The degree of postoperative pain</measure>
    <time_frame>First 24 hours postoperatively.</time_frame>
    <description>Postoperative pain will be assessed by Visual Analog scale (VAS) on admission to Post-Anesthesia Care unit (PACU) and at 30 minutes and then 1,2,4,6,12,18 and 24 hours postoperative.&#xD;
VAS (0-100; where 0 represents no pain and 100 represents the worst pain).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first rescue analgesia request.</measure>
    <time_frame>First 24 hours postoperatively.</time_frame>
    <description>Rescue analgesia in the form of morphine (3mg IV) will be given if the VAS is ≥ 40, repeated with lock out interval of 5 min guided with the occurrence of complications till the VAS is decreased to less than 40.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intraoperative fentanyl consumption.</measure>
    <time_frame>Intraoperative</time_frame>
    <description>Additional boluses of fentanyl 0.5 µg /kg will be administered in case of inadequate analgesia that defined as increase of heart rate (HR) and /or mean arterial blood pressure (MAP) more than 20 % from baseline</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Ultrasound-Guided</condition>
  <condition>Transeversus Thoracic Plane Blocks</condition>
  <condition>Pectoral Nerve (PECS) Block</condition>
  <condition>Serratus Anterior Plane Block</condition>
  <condition>Modified Radical Mastectomy</condition>
  <arm_group>
    <arm_group_label>Group I (pectoral nerve (PECS) block -transversus thoracic plane (TTP) block group)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive unilateral US-guided PECS II block and TTP block on the side of the operation after induction of general anesthesia.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group II (serratus anterior plane (SAP) block group)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients will receive US-guided SAP block after induction of general anesthesia.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pectoral nerve (PECS) block -transversus thoracic plane (TTP) block</intervention_name>
    <description>Patients will receive unilateral US-guided PECS II block and TTP block on the side of the operation after induction of general anesthesia.</description>
    <arm_group_label>Group I (pectoral nerve (PECS) block -transversus thoracic plane (TTP) block group)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Serratus anterior plane (SAP) block</intervention_name>
    <description>Patients will receive US-guided SAP block after induction of general anesthesia.</description>
    <arm_group_label>Group II (serratus anterior plane (SAP) block group)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Female patients&#xD;
&#xD;
          -  Aged 21-60 years&#xD;
&#xD;
          -  ASA physical status I, II&#xD;
&#xD;
          -  Scheduled for unilateral modified radical mastectomy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Patient refusal.&#xD;
&#xD;
          2. Known hypersensitivity to local anesthetics.&#xD;
&#xD;
          3. Body mass index &gt; 35 kg /m2.&#xD;
&#xD;
          4. Uncooperative or psychiatric patients.&#xD;
&#xD;
          5. Infection at the injection site.&#xD;
&#xD;
          6. Coagulation disorder.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>female</gender_description>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Alshaimaa S Alasrag, MBBCH</last_name>
    <phone>+201018940354</phone>
    <email>alshimaa33643@med.tanta.edu.eg</email>
  </overall_contact>
  <location>
    <facility>
      <name>Faculty of Medicine Tanta University</name>
      <address>
        <city>Tanta</city>
        <state>Elgharbia</state>
        <zip>31527</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alshaimaa S Alasrag, MBBCH</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 27, 2021</study_first_submitted>
  <study_first_submitted_qc>May 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 1, 2021</study_first_posted>
  <last_update_submitted>May 31, 2021</last_update_submitted>
  <last_update_submitted_qc>May 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tanta University</investigator_affiliation>
    <investigator_full_name>Alshaimaa Soliman Alasrag</investigator_full_name>
    <investigator_title>Resident at Anesthesiology, Surgical ICU and Pain medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aneurysm, Dissecting</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The data will be available upon reasonable request.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_time_frame>one year</ipd_time_frame>
    <ipd_access_criteria>The data will be available upon reasonable request.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

